Clinical trial
The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology
NCT01838564 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology
- Lead sponsor
- Dana-Farber Cancer Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2004
- Completion date
- June 30, 2010
- Enrollment
- 104 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
outcome assessment, palliative care, pediatric neoplasm, quality of life